A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry

Cancer Investigation

Volumn 24, Issue 8, 2006, Pages 747-753

  Liu, Xing Pan ^a   Shen, Jing ^a   Li, Zhen Fu ^a   Yan, Li ^a   Gu, Jin ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Biomarkers; Cancer detection; Colorectal cancer; Proteomics; SELDI TOF MS

Indexed keywords

BIOLOGICAL MARKER;

ADENOCARCINOMA; ADULT; AGED; ALGORITHM; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER STAGING; CASE CONTROL STUDY; CLASSIFICATION; COLORECTAL CARCINOMA; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MICROCHIP ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADENOCARCINOMA; BLOOD PROTEINS; COLORECTAL NEOPLASMS; HUMANS; NEOPLASM PROTEINS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 33845642036     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900601063873     Document Type: Article

References (19)

1. Brynmor, W.; Robert, S.; Shannon, B.; et al. Detection of early-stage cancer by serum protein analysis. American Laboratory June 2001, 32-36.
2. Smith, R.A.; Mettlin, C.S.; Davis, K.J.; et al. American cancer society guidelines for the early detection of cancer. CA Cancer J. Clin. 2000, 50(1), 34-49.
3. Crawford, N.P.; Colliver, D.W.; Galandiuk, S. Tumor markers and colorectal cancer: utility in management. J. Surg. Oncol. December 2003, 84(4), 239-248.
4. Duffy, M.J.; van Dalen, A.; Haglund, C.; et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur. J. Cancer. April 2003, 39(6), 718-727.
5. Feldman, A.L.; Espina, V.; Petricoin, E.F., 3rd; et al. Use of proteomic patterns to screen for gastrointestinal malignancies. Surgery March 2004, 135(3), 243-247.
6. Jemal, A.; Thomas, A.; Murray, T.; et al. Cancer Statistics 2002. CA Cancer J. Clin. 2002, 52, 23-47.
7. Srinivas, P.R.; Srivastava, S.; Hanash, S.; et al. Proteomics in early detection of cancer. Clin. Chem. 2001 (47), 1901-1911.
8. Merchant, M.; Weinberger, S.R. Recent advancements in surface enhanced laser desorption/ionization time-of-flight mass spectrometry. Electrophoresis 2000, 21, 1164-1167.
9. Wright, G.L. Jr.; Cazares, L.H.; Leung, S.M.; et al. ProteinChip surface enhanced laser desorption/ionization(SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostate Dis. 1999, 2, 264-276.
10. Hlavaty, J.L.; Partin, A.W.; Kusinitz, F.; et al. Mass spectrometry as a discovery tool for identifying serum markers for prostate cancer [Technical Brief]. Clin. Chem. 2001, 47, 1924-1926.
11. Sauter, E.R.; Zhu, W.; Fan, X.J.; et al. Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer. Br. J. Cancer 2002, 86, 1440-1443.
12. Vlahou, A.; Schellhammer, P.F.; Medrinos, S.; et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol. 2001, 158, 1491-1502.
13. Zhang, Z.; et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2001, 64, 5882-5890.
14. Jin, F.; Devesa, S.S.; Chow, W.H.; et al. Cancer incidence trends in urban Shanghai, 1972-1994: an update. Int. J. Cancer 1999, 83, 435-440.
15. Albrethsen, J.; et al. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer. Jan 2005, 19, 5-8.
16. Adam, B.L.; Qu, Y.; Davis, J.W.; et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 2002, 62, 3609-3614.
17. Jones, M.B; Krutzsch, H.; Shu, H.; et al. Petricoin. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2002, 2, 76-84.
18. Poon, T.C.W.; Johnson, P.J.; Proteome analysis and its impact on the discovery of serological tumor markers. Clin. Chim. Acta 2001, 313, 231-239.
19. Li, J.; Zhang, Z.; Rosenzweig, J.; et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 2002, 48(8), 1296-1304.